N/A N=37 Evaluation of the Ulthera® System for Treatment of the Brachia
Brachial Ptosis
Primary: Improvement in Obtaining Lift and Tightening of Brachial Skin Laxity — 48 percentage of participants improved
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 3 N=140 Study of the Safety and Efficacy of RVL-1201 in the Treatment of Acquired Blepharoptosis
Acquired Blepharoptosis
Primary: Mean Change in Number of Points Seen on the Leicester Peripheral Field Test (LPFT) in RVL-1201 Group vs. Vehicle Group — 5.2; 1.5; 6.4; 2.2 Points seen — p=<0.0001
Phase 2 N=46 Safety and Efficacy Study of RVL-1201 in Acquired Blepharoptosis
Blepharoptosis
Primary: Humphrey Visual Field — 9.8; 12.1; 11.1; 16.1 Points seen
N/A N=19 Clinical Trial to Improve the Magnetic Levator Prosthesis
Blepharoptosis · Ptosis, Eyelid · Myasthenia Gravis
Primary: Change in Interpalpebral Fissure During Eye Opening — 4.5; 6.9; 6.2; 6.3 millimeters — p=>=0.46
N/A N=16 Clinical Trial Comparing Two Non-Surgical Treatments for Severe Blepharoptosis
Blepharoptosis · Ptosis, Eyelid · Myasthenia Gravis
Primary: Interpalpebral Fissure (IPF) During Spontaneous Blink — 2.4; 4.1; 1.1 millimeters — p=<0.001
Phase 2 N=33 LEV102 Topical Gel in Acquired Blepharoptosis
Acquired Blepharoptosis
Primary: Percentage of Subjects With Treatment-Emergent Adverse Events [Safety and Tolerability]) — 0; 0; 0 Participants
Phase 3 N=164 Study of Safety and Efficacy of RVL-1201 in the Treatment of Blepharoptosis
Blepharoptosis
Primary: Mean Change in Number of Points Seen on the Leicester Peripheral Field Test (LPFT) in RVL-1201 Group vs. Vehicle Group — 6.3; 2.1; 7.7; 2.4 Points seen — p=<0.0001
Phase 4 N=18 Phenylephrine Versus Eyelid Taping for Muller's Muscle-Conjunctival Resection (MMCR) Evaluation
Ptosis, Eyelid
Primary: Mean MRD1 After Phenylephrine — 2.08 mm
N/A N=11 Magnetic Correction of Eye Lid Paralysis
Blepharoptosis · Lagophthalmos · Facial Paralysis
Primary: Rating Scale of Skin Integrity — 0.3 units on a scale
Early Phase 1 N=15 Topical Bimatoprost for Chemical Blepharoplasty
Dermatochalasis
Primary: Graded Change in Dermatochalasis — .2679 units on a scale
Phase 3 N=234 Study of Safety of RVL-1201 in Treatment of Blepharoptosis
Blepharoptosis
Primary: Mean Change From Baseline in Intraocular Pressure (IOP) at Day 84 — -0.6; -0.2; -0.6; -0.2 mmHg
Phase 4 N=43 The Effect of Lumify™ Eyedrops on Eyelid Position
Eyelid Droop
Primary: Palpebral Fissure Height — 9.64; 9.66; 9.92; 9.96 milimeter
N/A N=20 NMES Efficacy on Patients With NBPP
Neonatal Brachial Plexus Palsy
Primary: Change From Baseline in Upper Extremity Muscle Strength — 1; 1 score on a scale — p=0.40
N/A N=51 Rotator Cuff Tears in Hemiplegic Shoulder
Hemiplegia
Primary: Rotator Cuff Tear of the Hemiplegic Shoulder, Confirmed by Ultrasonography — 29 participants
N/A N=3 Robotic Hand Orthosis Providing Grasp Assistance for Patients With Brachial Plexus Injuries
Brachial Plexus Injury
Primary: Number of Successful Grasp Trials Per Participant Using Robotic Hand Orthosis — 13.2 Number of successful grabs of an object
Phase 4 N=21 Dose-Response Relationships for Hemidiaphragmatic Paresis Following Ultrasound-Guided Supraclavicular Block
Surgery of Right Upper Extremity
Primary: Number of Subjects With Hemidiaphragmatic Paresis at Various Volumes of Local Anesthetic 15 Minutes After Supraclavicular Block — 1; 1; 1; 2 Participants
N/A N=60 Assesment of Post-stroke Elbow Flexor Spasticity in Different Forearm Positions
Post-stroke Elbow Spasticity
Primary: Dynamic Component of Spasticity (Spasticity Angle) — 70; 60; 57.5 degree — p=<0.001
N/A N=47 Compression Stocking Use in Shoulder Arthroscopy in Beach Chair
Obesity · Shoulder Impingement
Primary: Cerebral Desaturation Event — 17; 22; 7; 1 Participants — p=.0553
N/A N=40 Photographic Assessment of Eyebrow Position and Range of Motion
Brow Ptosis
Primary: Eyebrow Position — -3.22 mm
N/A N=268 Nurse Reduction of Pulled Elbow
Radial Head Subluxation
Primary: Proportion of Patients With Successful Reduction of Radial Head Subluxation by Nurse, Compared With Physician Controls — 84.7; 96.7 percentage of patients reduced
N/A N=40 Symmetric vs Asymmetric BLR Recession in Management of Basic IXT With Ocular Dominance
Intermittent Exotropia
Primary: Ocular Alignment at Distant Fixation — 5.8; 1.1 prism diopter
N/A N=40 Neuromonitoring During the Latarjet Procedure
Shoulder Instability · Iatrogenic Nerve Injury
Primary: Neurologic Complication Rate After Latarjet Procedure — 7 participants
N/A N=80 Supraclavicular Brachial Plexus Block Using Ropivacaine Alone and With Dexmedetomidine
Brachial Plexus Anesthesia
Primary: Duration of Analgesia — 413.73; 197.35 minutes
N/A N=5 Brasthesis Prosthetic Harness for Women Veterans With Upper Limb Amputations
Upper Limb Amputation
Primary: Change in Prosthetic Function and Satisfaction Using the Orthotic and Prosthetic Users Survey (OPUS) — 73 Units on a scale
Phase 2 N=171 BOTOX® for the Treatment of Platysma Prominence
Platysma Prominence
Primary: Percentage of Participants With at Least 1-Grade Improvement at Day 14 as Rated by Investigator Using the Clinician Allergan Platysma Prominence Scale (C-APPS) — 12.0…
Phase 3 N=48 A Study to Compare Sublingual Cannabis Based Medicine Extracts With Placebo to Treat Brachial Plexus Injury Pain
Pain
Primary: Change From Baseline in the Mean Box Scale-11 Pain Review Score at the End of Each Treatment Period (Each Lasting 14-20 Days) — -0.6; -0.6; 0.0 units on a scale — p=0.005
Phase 1 N=110 The Study of Regional Hemodynamic Changes After Specific Brachial Plexus Block by Ultrasound Guidance
Upper Limb Nerve Block
Primary: Changes in Hemodynamic Parameters of Radial/Ulnar Artery From Baseline to 30min After Specific Nerve Block Followed by 30min After Brachial Plexus Block(Phase 1) — 40.9…
Phase 4 N=65 Comparison of Two Botulinum Type A Products in the Treatment of Blepharospasm
Blepharospasm
Primary: Change From Baseline to Week 4 in Blepharospasm Disability Index — -2.8; -1.3 Points on Scale
Phase 3 N=61 Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Abnormal Contraction or Twitch of the Eyelid
Bilateral Blepharospasm (BEB)
Primary: Double-blind MP: Change From Baseline in JRS Severity Subscore at Day 43 (Visit 4) — -0.6; -1.0; -1.8 score on a scale — p==0.0004
N/A N=167 Restoring the Anatomic Tension Relationship of the Long Head of the Biceps During Tenodesis
Biceps Tendon Disorder · Tendinosis · Rotator Cuff Injuries
Primary: Comparison of American Shoulder and Elbow Surgeon (ASES) Score Between Treatment and Control Groups — 47.1; 37.1 units on a scale